SAN DIEGO–(BUSINESS WIRE)– #cellandgenetherapy–Nucleus Biologics Launches NB-KUL™ DF, A DMSO-Free, Chemically-Defined Cryomedia. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech NetworksSAN DIEGO and AUSTIN, Texas and HAMILTON, ON, Oct. 15, 2024 /PRNewswire/ — Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells [...]SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced [...]Researchers from the San Diego Supercomputer Center, part of the School of Computing, Information and Data Sciences (SCIDS) at UC San Diego, have launched a new initiative to advance science and technology that addresses wildland [...]Eli Lilly’s Gateway Labs is going global, with the U.K. government announcing today that the nation will host the first European branch of the incubator program. The Gateway Labs are co-working spaces for researchers that [...]SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Tri-City Healthcare District (“Tri-City”) announces a data incident that impacted some protected health information stored on its network. On November 9, 2023, Tri-City detected suspicious activity on its [...]UC San Diego professors discuss the status of democracy worldwide. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech NetworksMIDDLETON, Wis., Oct. 14, 2024 /PRNewswire/ — Natus Medical Incorporated’s innovation in ICU solutions will be on display Oct. 14-18, in San Diego when the leader in neurocritical care technologies participates in the 22nd Annual [...]From better algorithms for self-driving vehicles, to better solutions for robotics surgery, and better ways for robots to manipulate objects, researchers at the University of California San Diego are presenting their work at the IROS [...]Honorees represent the best of those who make a profound impact on the lives of employees with injuries and disabilities SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Four case managers are being celebrated for their [...]By Jula Inrig, M.D. Chief Medical Officer, Travere TherapeuticsWhen a specialized field of medicine has long been quiet, a buzz of breakthrough can seem like a sudden development. The reality is more nuanced. The fact [...]SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (“Kintara”) (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced a record date of October 17, 2024 [...]SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that Adi Mohanty, CEO of Biora Therapeutics, will present on the company’s 00-size BioJet™ [...]Profile insights Find out how your skills align with the job description Skills Do you have experience in Statistics? Education Do you have a Doctoral… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Supervising experience? Education Do you have a… Click here to view original postAbout the job We are seeking highly motivated candidates to join our R&D team in San Diego, where… Click here to view original postVentyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Research & development? Education Do you have… Click here to view original postTAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that FDA issues Study [...]LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion. As part of the deal, which is expected [...]The Merlin test (CP-GEP) stratifies melanoma patients based on risk for sentinel lymph node (SLN) metastasis, offering a powerful tool for risk-based decision-making. ROTTERDAM, Netherlands and SAN DIEGO, Oct. 13, 2024 /PRNewswire/ — SkylineDx, an [...]We are the makers of possible BD is one of the largest global medical technology companies in the… Click here to view original postSan Diego, CA Regulatory & Quality – Quality Control / Exempt… Click here to view original postDepartment: 104200 HCP Marketing Location: San Diego, USA- Remote Be a part of a… Click here to view original postWelcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to [...]Job Summary Hologic is seeking a Change Analyst I, responsible for scanning, maintaining device history documents/records, and routing change… Click here to view original post